In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 30 for your search:
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase IV
Type: Behavioral study
Status: Active
Age: 51 to 84
Sponsor: NCI, Other
Protocol IDs: FCM001, R01CA132935, NCT01332032

2.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00702, CDR0000615085, NSABP-B-43, U10CA012027, NCT00769379

4.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 08-308, R01CA139118, NCT00959985

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1005, NCI-2011-02669, CDR0000700069, NCT01349322

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention, Treatment
Status: Approved-not yet active
Age: 25 to 55
Sponsor: NCI, Other
Protocol IDs: A211102, U10CA031946, NCI-2013-00995, NCT01905046

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644921, UPCC-15107, 807010, NCT00923143

8.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000651359, OSU-08177, 2009C0041, NCT01008514

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: S0812, U10CA037429, NCI-2011-02032, SWOG-S0812, NCT01097278

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000675211, P30CA022453, WSU-2010-056, 2010-056, NCT01147016

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000701992, CALGB-40903, NCT01439711

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: I 108907, NCI-2009-01568, P30CA016056, NCT01754519

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Postmenopausal
Sponsor: NCI
Protocol IDs: NCI-2013-00757, UAZ08-12-02, 09-0869-04, N01CN35158, P30CA023074, UARIZ-09-0869-04, UARIZ-UAZ08-12-02, NCT01077453

15.

Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: CASE1105, P30CA043703, NCT00445445

16.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00875, 2008-0086, CDR0000573719, H-19895, P50-CA-58183, P50CA058183, P30CA016672, MDA-P50-CA-58183, BCM-H-19895, BCM-P50-CA-58183, NCT00555152

17.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 311-06, P30CA036727, UNMC-31106, NCT00666731

18.

Phase: No phase specified
Type: Diagnostic
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000616972, UCSF-H7987-32292-01B, H7987-32292-01B, NCT00804128

19.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000633754, UCD-CCSO001, 200816282-1, CCSO001, NCT00859157

20.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Status: Active
Age: 18 to 90
Sponsor: NCI
Protocol IDs: 090120, 09-C-0120, NCT00923104

21.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 18 to 90
Sponsor: NCI
Protocol IDs: 090100, 09-C-0100, NCT00924027

22.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000671157, ECOG-E5194T1, E5194T1, ECOG E5194A-ECOG-ICSC, NCT01132560

23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-13311, NCI-2010-02342, P30CA016059, NCT01293032

24.

Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Status: Active
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: ZCC-2010, U54CA142152-02, NCT01400399

25.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 11-0119, 1K07CA154850-01A1, NCT01488357
1   
New Search